The proliferation of substandard medicines represents a deeply concerning challenge facing the global medical landscape. These deceptive products, often mimicking legitimate medications, pose a significant danger to individual safety, undermining therapy effectiveness and potentially leading to severe harmful health outcomes. Motivated by substanti